Evaluación de la enfermedad de Alzheimer en etapa temprana: biomarcadores y pruebas neuropsicológicas

dc.contributor.advisor
dc.contributor.author	Lanfranco G., Renzo
dc.contributor.author	Manríquez Navarro, Paula
dc.contributor.author	Avello G., Leyla
dc.contributor.author	Canales Johnson, Andrés
dc.date.accessioned	2016-11-11T19:29:03Z
dc.date.available	2016-11-11T19:29:03Z
dc.date.issued	2012
dc.description.abstract	Alzheimer disease is a neurodegenerative condition that affects cognitive, behavioral and global functioning of patients. Currently and due to the lack of conclusive biological testing, Alzheimer's disease diagnosis is based primarily on clinical criteria. Since its early diagnosis allows clinical interventions when neurological damage is relatively mild, the development of early detection tools has become a major topic of interest. In this article, we review the main neurobiological and neuropsychological features of Alzheimer's disease, analyzing the use of biomarkers and neuropsychological testing for early detection. (Rev Med Chile 2012; 140: 1191-1200).
dc.identifier.citation	Revista Médica de Chile, 2012,140, n° 9, p. 1191-1200
dc.identifier.uri	http://hdl.handle.net/11447/824
dc.language.iso	en_US
dc.subject	Alzheimer disease
dc.subject	Biological markers
dc.subject	Neurobiology
dc.subject	Neuropsychology
dc.title	Evaluación de la enfermedad de Alzheimer en etapa temprana: biomarcadores y pruebas neuropsicológicas
dc.title.alternative	Early evaluation of Alzheimer’s disease: biomarkers and neuropsychological tests
dc.type	Artículo

Files

Now showing 1 - 1 of 1